HOME >> BIOLOGY >> NEWS
Protein key to trafficking in nerve terminals

A protein characterized by researchers at Baylor College of Medicine plays an important role in communication between neurons. This protein is overactive (up-regulated) in children with Down's Syndrome.

Identifying this protein - Dap160 — and its function is an important step in understanding how neurons communicate with one another, said Dr. Hugo Bellen, BCM professor of molecular and human genetics, a Howard Hughes Medical Institute investigator, and director of the program in developmental biology. The report appears in the July 22, 2004, issue of the journal Neuron.

Dap 160 was found as part of a new screen developed in Bellen's laboratory. The screen revealed many genes involved in neuronal function and development, said Bellen. Dap160 stands for Dynamin-associated protein of 160 kD (kilodaltons). Dynamin is a protein that is crucial to the final portion of the synaptic process.

Neurotransmitters are the chemicals that contain the message to be transmitted when neurons talk to each other or to other cells. These chemicals are contained in small vesicles inside nerve endings called synapses.

When a nerve pulse invades the nerve ending, these vesicles fuse with the membrane at the tip of the nerve ending (called the synaptic membrane). At this point, vesicles release their contents so that a nearby cell receives the message.

"You need to retrieve the vesicles at the synapse to maintain a constant supply of vesicles in the nerve terminal," said Bellen. At least two distinct types of vesicle retrieval occur at the synapse, but the most well studied mechanism of vesicle retrieval is based on retrieving little pieces of membrane from the synaptic membrane. As the vesicles start to bud off the cell membrane, dynamin accumulates on the vesicle. The role of this protein is still controversial, Bellen said. Some people think it's a "pinchase," pinching the vesicle off the cell membrane. Others think that
'"/>

Contact: Ross Tomlin
htomlin@bcm.tmc.edu
713-798-4712
Baylor College of Medicine
22-Jul-2004


Page: 1 2

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein controls acid in cells by direct detection of volume changes, study finds
8. Protein believed to control formation of memory identified by Scripps & UCSD scientists
9. Protein stops blood-vessel growth, holds promise as cancer therapy
10. Proteins transform DNA into molecular velcro
11. Protein engineered to detect nerve gas

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2019)... ... June 14, 2019 , ... Emtec, Inc.®, ... deliver a joint presentation with Versiti’s CIO at the Healthcare Industry User ... Shingle Creek Resort. , Versiti Vice President and Chief Information Officer, Lynne Briggs, ...
(Date:6/11/2019)... ... June 12, 2019 , ... ... services, Abveris plans to leverage the Geneious Biologics platform as a premium hub ... Technology Officer at Abveris, says: “The Geneious team has done an excellent job ...
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, a specialty investment ... Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. , Headquartered ... services to more than one dozen hospitals and surgery centers in the Dallas-Fort ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel ... report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also ... report, Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel is a ...
(Date:7/9/2019)... ... July 08, 2019 , ... ... SmartLight Indicator was recognized as the 2019 Innovative Product of the Year which ... prestigious awards were during Sensors Expo & Conference 2019, held this ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/11/2019)... , ... June 10, 2019 , ... ... its distribution network with the appointment of Biofeedback Tech Ltd as ... systems are an essential part of many therapeutic treatments and clinical assessment protocols ...
Breaking Biology Technology:
Cached News: